Free Trial

Axsome Therapeutics (AXSM) Insider Trading & Ownership

Axsome Therapeutics logo
$94.60 -0.86 (-0.90%)
(As of 11/20/2024 ET)

Axsome Therapeutics (NASDAQ:AXSM) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
22.40%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
5
Amount Of
Insider Selling
(Last 12 Months)
$10.01 M
Get AXSM Insider Trade Alerts

Want to know when executives and insiders are buying or selling Axsome Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

AXSM Insider Buying and Selling by Quarter

Axsome Therapeutics Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/11/2024Mark E SaadDirectorSell11,016$91.31$1,005,870.96  
8/9/2024Mark L JacobsonCOOSell47,739$84.26$4,022,488.14  
5/29/2024Mark L JacobsonCOOSell7,910$74.31$587,792.10  
5/28/2024Mark ColemanDirectorSell5,249$75.21$394,777.29  
4/1/2024Mark L. JacobsonCOOSell24,662$77.24$1,904,892.88  
3/14/2024Roger JeffsDirectorSell29,976$69.70$2,089,327.20  
(Data available from 1/1/2013 forward)

AXSM Insider Trading Activity - Frequently Asked Questions

The list of insiders at Axsome Therapeutics includes Mark Coleman, Mark E Saad, Mark L Jacobson, and Roger Jeffs. Learn more on insiders at AXSM.

22.40% of Axsome Therapeutics stock is owned by insiders. Learn more on AXSM's insider holdings.

The following insiders have sold AXSM shares in the last 24 months: Mark Coleman ($1,223,070.33), Mark E Saad ($1,005,870.96), Mark L Jacobson ($4,610,280.24), and Roger Jeffs ($2,089,327.20).

Insiders have sold a total of 137,568 Axsome Therapeutics shares in the last 24 months for a total of $10,833,441.61 sold.

Axsome Therapeutics Key Executives



This page (NASDAQ:AXSM) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners